Advertisement

T-Lymphocyte Tolerance in RNA Tumor Virus Oncogenesis: A Model for the Clonal Abortion Hypothesis

  • Luigi Chieco-Bianchi
  • Dino Collavo
  • Giovanni Biasi
  • Paola Zanovello
  • Franca Ronchese
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 57)

Abstract

Retrovirus genes are contained in the chromosomal DNA of most vertebrates and may be transmitted vertically from parent to offspring through the germ line, as well as horizontally as infectious virus particles.

Keywords

Spleen Cell Immunological Tolerance Murine Sarcoma Virus Lytic Unit Immunological Unresponsiveness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    P. Duesberg, and K. Bister, Transforming genes of retroviruses: definition, specificity and relation to cellular DNA, in: “Cancer: Achievements, Challenges and Prospects for the 1980s,” (J.H. Burchenal and H.F. Oettgen eds.) Vol. 1, p. 111, Grune and Stratton, New York (1981).Google Scholar
  2. 2.
    M.S. McGrath, E. Pillemer, D. Kooistra, and I.L. Weissman, The role of MuLV receptors on T-lymphoma cells in lymphoma cell proliferation, in “Contemporary Topics in Immunobiology, ” (N.L. Warner, ed.), Vol. 11, p. 157, Plenum Press, New York/London (1980).CrossRefGoogle Scholar
  3. 3.
    W. Hayward, B. Neel, and S. Astrin, Activation of a cellular oncogene by promoter insertion in ALV-indueed lymphoid leukosis, Nature (London), 290: 475 (1981).CrossRefGoogle Scholar
  4. 4.
    L. Chieco-Bianchi, and D. Collavo, Some illustrative systems of viral carcinogenesis: The leukemia-sarcoma virus complex in the mouse, in: “Scientific Foundations of Oncology” (T. Symington and R.L. Carter eds.), p. 388, William Heinemann Medical Books Ltd, London (1977).Google Scholar
  5. 5.
    L. Chieco-Bianchi, A. Colombatti, D. Collavo, F. Sendo, T. Aoki, and P.J. Fischinger, Tumor induction by murine sarcoma virus in AKR and C58 mice: reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes, J. Exp. Med., 140: 1162 (1974).CrossRefGoogle Scholar
  6. 6.
    J.P. Levy, and J.C. Ledere, The murine sarcoma virus induced tumors: exception or general model in tumor immunology? Adv. Cancer Res., 24: 1 (1977).CrossRefGoogle Scholar
  7. 7.
    D. Collavo, A. Colombatti, L. Chieco-Bianchi, and A.J.S. Davies, T-lymphocyte requirement for MSV tumor prevention or regression, Nature, (London) 249: 169 (1974).CrossRefGoogle Scholar
  8. 8.
    O. Stutman, Delayed tumour appearance and absence of regression in nude mice infected with murine sarcoma virus, Nature (London), 253: 142 (1975).CrossRefGoogle Scholar
  9. 9.
    F. Plata, J.C. Cerottini, and K.T. Brunner. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system. Eur. J. Immunol., 5: 227 (1975).CrossRefGoogle Scholar
  10. 10.
    D. Collavo, A. Parenti, G. Biasi, L. Chieco-Bianchi, and A. Colombatti, Secondary in vitro generation of cytolytic T lymphocytes (CTLs) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier, J. Natl. Cancer Inst., 61: 885 (1978).Google Scholar
  11. 11.
    L. Chieco-Bianchi, D. Collavo, A. Colombatti, G. Biasi, A. Parenti, E. D’Andrea, and A. De Rossi, Multifactorial control of M-MSV tumor induction and progression, in; “Tumor-associated Antigens and their Specific Immune Response” F. Spreafico and R. Arnon, eds.), p. 71, Academic Press, London (1979).Google Scholar
  12. 12.
    D. Collavo, P. Zanovello, G. Biasi, and L. Chieco-Bianchi, T lymphocyte tolerance and early appearance of virus induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice, J. Immunol., 126: 187 (1981).Google Scholar
  13. 13.
    W.H. Burns, and A.C. Allison, Virus infections and the immune responses they elicit, in: “The Antigens” (M. Sela, ed.), Vol. 3, p. 479, Academic Press, New York (1975).Google Scholar
  14. 14.
    F.M. Burnet, and F. Fenner, The Production of Antibodies, Mac Millan, Melbourne (1949).Google Scholar
  15. 15.
    D.E. Parks, and W.O. Weigle, Current perspectives on the cellular mechanisms of immunological tolerance, Clin. Exper. Immunol., 39: 257 (1980).Google Scholar
  16. 16.
    G.J.V. Nossal, and B.L. Pike, Antibody receptor diversity and diversity of signals, in: “Progress in Immunology 80,” M. Fougereau and J. Dausset, eds.), Vol. 1, p. 136, Academic Press, London (1980).Google Scholar
  17. 17.
    C. Fernandez, and G. Möller, Irreversible immunological tolerance to thymus-independent antigens is restricted to the clone of B-cells having both Ig and PBA receptors for the tolerogen, Scand. J. Immunol., 7: 137 (1978).Google Scholar
  18. 18.
    J.A. Myburgh and N.A. Mitchison, Suppressor mechanism in neonatally acquired tolerance to a Gross virus-induced lymphoma in rats. Transplantation 22: 236 (1976).CrossRefGoogle Scholar
  19. 19.
    I. Kamo and H. Friedman, Immunosuppression and the role of suppressive factors in cancer, Adv. Cancer Res., 25: 271 (1977).CrossRefGoogle Scholar
  20. 20.
    C.P. Plater, P. Debré, and J.C. Leclerc, T cell-mediated immunity to oneorna-virus-induced tumor. III. Specific and non specific suppression in tumor-bearing mice, Eur. J. Immunol. 11: 39 (1981).CrossRefGoogle Scholar
  21. 21.
    D. Collavo, F. Ronchese, P. Zanovello, G. Biasi, and L. Chieco-Bianchi, T cell tolerance in Moloney-murine leukemia virus (M-MuLV) carrier mice low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors, J. Immunol., 28: 774 (1982).Google Scholar
  22. 22.
    K.T. Brunner, H.R. MacDonald, and J.C. Cerottini, Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. II. Analysis of the clonal progeny of CTL precursors stimulated in vitro with syngeneic tumor cells, J. Immunol., 124: 1627 (1980).Google Scholar
  23. 23.
    G. Klein and E. Klein, Immunological tolerance of neonatally infected mice to the Moloney leukemia virus. Nature (London) 209: 163 (1966).CrossRefGoogle Scholar
  24. 24.
    L. Chieco-Bianchi, L. Fiore-Donati, G. Tridente, and N. Pennelli, Graffi virus and immunological tolerance in leukaemogenesis, Nature (London), 214: 1227 (1967).CrossRefGoogle Scholar
  25. 25.
    L. Chieco-Bianchi, F. Sendo, T. Aoki, and O.L. Barrera, Immuno-logical tolerance to antigens associated with murine leukemia viruses: T-cell unresponsiveness ? J. Natl. Cancer Inst., 52: 1345 (1974).Google Scholar
  26. 26.
    G.J.V. Nossal and B.L. Pike, Evidence for the clonal abortion theory of B-lymphocyte tolerance, J. Exp. Med., 141: 904 (1975).Google Scholar
  27. 27.
    E.S. Metcalf and N.R. Keinman, In vitro tolerance induction of neonatal murine B cells, J. Exp. Med. 143:1327 (1976).CrossRefGoogle Scholar
  28. 28.
    G.J.V. Nossal and B.L. Pike, Functional clonal deletion in immunological tolerance to major histocompatibility complex antigens, Proc. Natl. Acad. Sci. USA, 78: 3844 (1981).CrossRefGoogle Scholar
  29. 29.
    L. Chieco-Bianchi, L. Fiore-Donati, D. Collavo, and G. Tridente, Immunological problems in virus-induced leukemia in the mouse, in “Immunity and Tolerance in Oncogenesis” (L. Severi, ed.), p. 599, Division of Cancer Research, Perugia (1970).Google Scholar
  30. 30.
    J. Lee, I. Horak, and J. Ihle, Mechanisms in T cell leukemo- genesis. II. T cell responses of preleukemic BALB/c mice to Moloney leukemia virus antigens, J. Immunol 126: 715 (1981).Google Scholar
  31. 31.
    J. Lee and J. Ihle, Chronic immune stimulation is required for Moloney leukaemia virus-induced lymphomas, Nature (London), 289: 407, 1981.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • Luigi Chieco-Bianchi
    • 1
  • Dino Collavo
    • 1
  • Giovanni Biasi
    • 1
  • Paola Zanovello
    • 1
  • Franca Ronchese
    • 1
  1. 1.Laboratory of OncologyUniversity of PadovaItaly

Personalised recommendations